VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
42 hedge funds and large institutions have $18.6M invested in Vincerx Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
42
Holding in Top 10
–
Calls
$1.47M
Puts
–
Top Buyers
| 1 | +$423K | |
| 2 | +$297K | |
| 3 | +$269K | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$171K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$104K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$143K | |
| 3 | -$142K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$93K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$82.4K |